Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CD4(+)' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 8122 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pomerantz, RJ
      Reservoirs of human immunodeficiency virus type 1: The main obstacles to viral eradication

      CLINICAL INFECTIOUS DISEASES
    2. Carey, KD; Stork, PJS
      Nonisotopic methods for detecting activation of small G proteins

      G PROTEIN PATHWAYS: PT C, EFFECTOR MECHANISMS
    3. Doruker, P; Bahar, I; Baysal, C; Erman, B
      Collective deformations in proteins determined by a mode analysis of molecular dynamics trajectories

      POLYMER
    4. Foley, HD; Otero, M; Orenstein, JM; Pomerantz, RJ; Schnell, MJ
      Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1)envelopes display HIV-1-like tropism and target human dendritic cells

      JOURNAL OF VIROLOGY
    5. Kattan, M; Platzker, A; Mellins, RB; Schluchter, MD; Chen, XC; Peavy, H; Steinbach, S; Wohl, ME; Hiatt, P; Hunter, J; Colin, AA
      Respiratory diseases in the first year of life in children born to HIV-1-infected women

      PEDIATRIC PULMONOLOGY
    6. Bertalot, G; Villanacci, V; Gramegna, M; Orvieto, E; Negrini, R; Saleri, A; Terraroli, C; Ravelli, R; Cestari, R; Viale, G
      Evidence of Epstein-Barr virus infection in ulcerative colitis

      DIGESTIVE AND LIVER DISEASE
    7. Romero-Rojas, A; Ponce-Hernandez, C; Mendoza, SE; Reyes-Esparza, JA; Estrada-Parra, S; Hadden, JW
      Immunomodulatory properties of Mycoplasma pulmonis. II. Studies on the mechanisms of immunomodulation

      INTERNATIONAL IMMUNOPHARMACOLOGY
    8. Tran, GT; Carter, N; Hodgkinson, SJ
      Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis

      INTERNATIONAL IMMUNOPHARMACOLOGY
    9. Trobonjaca, Z; Radosevic-Stasic, B; Crncevic, Z; Rukavina, D
      Modulatory effects of octreotide on anti-CD3 and dexamethasone-induced apoptosis of murine thymocytes

      INTERNATIONAL IMMUNOPHARMACOLOGY
    10. Ross, R; Reske-Kunz, AB
      The role of NO in contact hypersensitivity

      INTERNATIONAL IMMUNOPHARMACOLOGY
    11. Cho, YK; Sung, H; Lee, HJ; Joo, CH; Cho, GJ
      Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed

      INTERNATIONAL IMMUNOPHARMACOLOGY
    12. Oka, H; Emori, Y; Kobayashi, N; Hayashi, Y; Nomoto, K
      Suppression of allergic reactions by royal jelly in association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses

      INTERNATIONAL IMMUNOPHARMACOLOGY
    13. Verhasselt, V; Goldman, M
      New concepts on the pathogenesis of autoimmune disease

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    14. Cooke, A; Phillips, JM; Parish, NM
      Tolerogenic strategies to halt or prevent type I diabetes

      NATURE IMMUNOLOGY
    15. Akbari, O; DeKruyff, RH; Umetsu, DT
      Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen

      NATURE IMMUNOLOGY
    16. Sperling, AI; Bluestone, JA
      ICOS costimulation: it's not just for T(H)2 cells anymore

      NATURE IMMUNOLOGY
    17. Liu, YJ; Kanzler, H; Soumelis, V; Gilliet, M
      Dendritic cell lineage, plasticity and cross-regulation

      NATURE IMMUNOLOGY
    18. Camacho, SA; Heath, WR; Carbone, FR; Sarvetnick, N; LeBon, A; Karlsson, L; Peterson, PA; Webb, SR
      A key role for ICAM-I in generating effector cells mediating inflammatory responses

      NATURE IMMUNOLOGY
    19. Rothenberg, EV
      Notchless T cell maturation?

      NATURE IMMUNOLOGY
    20. Latchman, Y; Wood, CR; Chernova, T; Chaudhary, D; Borde, M; Chernova, I; Iwai, Y; Long, AJ; Brown, JA; Nunes, R; Greenfield, EA; Bourque, K; Boussiotis, VA; Carter, LL; Carreno, BM; Malenkovich, N; Nishimura, H; Okazaki, T; Honjo, T; Sharpe, AH; Freeman, GJ
      PD-L2 is a second ligand for PD-I and inhibits T cell activation

      NATURE IMMUNOLOGY
    21. Yang, JF; Zhu, H; Murphy, TL; Ouyang, WJ; Murphy, KM
      IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production

      NATURE IMMUNOLOGY
    22. McIntire, JJ; Umetsu, SE; Akbari, O; Potter, M; Kuchroo, VK; Barsh, GS; Freeman, GJ; Umetsu, DT; DeKruyff, RH
      Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family

      NATURE IMMUNOLOGY
    23. Gonzalez, A; Andre-Schmutz, I; Carnaud, C; Mathis, D; Benoist, C
      Damage control, rather than unresponsiveness, effected by protective DX5+Tcells in autoimmune diabetes

      NATURE IMMUNOLOGY
    24. Ohteki, T; Suzue, K; Maki, C; Ota, T; Koyasu, S
      Critical role of IL-15-IL-15R for antigen-presenting cell functions in theinnate immune response

      NATURE IMMUNOLOGY
    25. Leung, RKM; Thomson, K; Gallimore, A; Jones, E; Van den Broek, M; Sierro, S; Alsheikhly, AR; McMichael, A; Rahemtulla, A
      Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment

      NATURE IMMUNOLOGY
    26. Schaeffer, EM; Yap, GS; Lewis, CM; Czar, MJ; McVicar, DW; Cheever, AW; Sher, A; Schwartzberg, PL
      Mutation of Tec family kinase alters T helper cell differentiation

      NATURE IMMUNOLOGY
    27. Kishimoto, H; Sprent, J
      A defect in central tolerance in NOD mice

      NATURE IMMUNOLOGY
    28. Biedermann, T; Zimmermann, S; Himmelrich, H; Gumy, A; Egeter, A; Sakrauski, AK; Seegmuller, I; Voigt, H; Launois, P; Levine, AD; Wagner, H; Heeg, K; Louis, JA; Rocken, M
      IL-4 instructs T(H)1 responses and resistance to Leishmania major in susceptible BALB/c mice

      NATURE IMMUNOLOGY
    29. de Jong, YP; Abadia-Molina, AC; Satoskar, AR; Clarke, K; Rietdijk, ST; Faubion, WA; Mizoguchi, E; Metz, CN; Al Sahli, M; ten Hove, T; Keates, AC; Lubetsky, JB; Farrell, RJ; Michetti, P; van Deventer, SJ; Lolis, E; David, JR; Bhan, AK; Terhorst, C
      Development of chronic colitis is dependent on the cytokine MIF

      NATURE IMMUNOLOGY
    30. Bogdan, C
      Nitric oxide and the immune response

      NATURE IMMUNOLOGY
    31. Revy, P; Sospedra, M; Barbour, B; Trautmann, A
      Functional antigen-independent synapses formed between T cells and dendritic cells

      NATURE IMMUNOLOGY
    32. Skowron, G; Street, JC; Obee, EM
      Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    33. Gerna, G; Piccinini, G; Genini, E; Percivalle, E; Zavattoni, M; Lilleri, D; Testa, L; Comolli, G; Maserati, T; Baldanti, F; Maccario, R; Monforte, AD; Revello, MG
      Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    34. Babiker, A; Darbyshire, N; Pezzotti, P; Porter, K; Rezza, G; Walker, S; Beral, V; Coutinho, R; Del Amo, J; Gill, N; Lee, C; Meyer, L; Tyrer, F; Dabis, F; Thiebaut, R; Lawson-Ayayi, S; Meyer, L; Boufassa, F; Hamouda, O; Lorenzo, JI; Touloumi, G; Hatzakis, A; Karafoulidou, A; Katsarou, O; Brettle, R; del Romero, J; Prins, M; Coutinho, RA; van Benthem, B; Coutinho, RA; Kirk, O; Pedersen, C; Aguado, IH; Perez-Hoyos, S; Eskild, A; Bruun, JN; Sannes, M; Sabin, C; Johnson, AM; Phillips, AN; Darbyshire, JH; Francioli, P; Vanhems, P; Egger, M; Rickenbach, M; Cooper, D; Kaldor, J; Vizzard, J; Tusell, JM; Ruiz, I; Cayla, JA; de Olalla, PG; Day, NE; De Angelis, D
      Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    35. Cramer, LA; Frelinger, JA
      Dendritic cells transduced with HIV Nef express normal levels of HLA-A andHLA-B Class I molecules

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    36. Huang, MB; Khan, MF; Garcia-Barrio, M; Powell, M; Bond, VC
      Apoptotic effects in primary human umbilical vein endothelial cell cultures caused by exposure to virion-associated and cell membrane-associated HIV-1 gp120

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    37. Lucas, GM; Cheever, LW; Chaisson, RE; Moore, RD
      Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    38. Ungsedhapand, C; Kroon, EDMB; Suwanagool, S; Ruxrungtham, K; Yimsuan, N; Sonjai, A; Ubolyam, S; Buranapraditkun, S; Tiengrim, S; Pakker, N; Kunanusont, C; Lange, JMA; Cooper, DA; Phanuphak, P
      A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    39. Tarwater, PM; Margolick, JB; Jin, JH; Phair, JP; Detels, R; Rinaldo, C; Giorgi, J; Munoz, A
      Increase and plateau of CD4 T-cell counts in the 3 1/2 years after initiation of potent antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    40. Brambilla, AM; Castagna, A; Nocita, B; Hasson, H; Boeri, E; Veglia, F; Lazzarin, A
      Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    41. Funk, GA; Fischer, M; Joos, B; Opravil, M; Gunthard, HF; Ledergerber, B; Bonhoeffer, S
      Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    42. Sabin, CA; Fisher, M; Churchill, D; Pozniak, A; Hay, P; Easterbrook, P; Williams, I
      Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    43. Girardi, E; Palmieri, F; Cingolani, A; Ammassari, A; Petrosillo, N; Gillini, L; Zinzi, D; De Luca, A; Antinori, A; Ippolito, G
      Changing clinical presentation and survival in HIV-associated tuberculosisafter highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    44. Saha, K; Zhang, JC; Zerhouni, B
      Evidence of productively infected CD8(+) T cells in patients with AIDS: Implications for HIV-1 pathogenesis

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    45. Talal, AH; Irwin, CE; Dieterich, DT; Yee, H; Zhang, LQ
      Effect of HIV-1 infection on lymphocyte proliferation in gut-associated lymphoid tissue

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    46. Abgrall, S; Matheron, S; Le Moing, V; Dupont, C; Costagliola, D
      Pneumocystis carinii pneumonia recurrence in HIV patients on highly activeantiretroviral therapy: Secondary prophylaxis

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    47. Didier, JM; Kazatchkine, MD; Demouchy, C; Moat, C; Diagbouga, S; Sepulveda, C; Di Lonardo, AM; Weiss, L
      Comparative assessment of five alternative methods for CD4(+) T-lymphocyteenumeration for implementation in developing countries

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    48. Talal, AH; Monard, S; Vesanen, M; Zheng, ZY; Hurley, A; Cao, YZ; Fang, F; Smiley, L; Johnson, J; Kost, R; Markowitz, MH
      Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    49. Lafeuillade, A; Poggi, C; Chadapaud, S; Hittinger, G; Chouraqui, M; Pisapia, M; Delbeke, E
      Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    50. Becker, SL; Raffanti, SR; Hansen, NI; Fusco, JS; Fusco, GP; Slatko, GH; Igboko, EF; Graham, NMH
      Zidovudine and stavudine sequencing in HIV treatment planning: Findings from the CHORUS HIV cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    51. Thaler, S; Schnierle, BS
      A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes

      MOLECULAR THERAPY
    52. Bronte, V; Serafini, P; Apolloni, E; Zanovello, P
      Tumor-induced immune dysfunctions caused by myeloid suppressor cells

      JOURNAL OF IMMUNOTHERAPY
    53. Szabo, J; Cervenak, L; Toth, FD; Prohaszka, Z; Horvath, L; Kerekes, K; Beck, Z; Bacsi, A; Erdei, A; Peerschke, EIB; Fust, G; Ghebrehiwet, B
      Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures

      CLINICAL IMMUNOLOGY
    54. Anthony, DD; Post, AB; Valdez, H; Peterson, DL; Murphy, M; Heeger, PS
      ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producingperipheral blood lymphocytes in infected humans with and without cirrhosis

      CLINICAL IMMUNOLOGY
    55. Wilhelm, M; Weissinger, F; Kunzmann, V; Muller, JG; Fahey, JL
      Idiopathic CD4(+) T cell lymphocytopenia evolving to monoclonal immunoglobulins and progressive renal damage responsive to IL-2 therapy

      CLINICAL IMMUNOLOGY
    56. Miller, KD; Spooner, K; Herpin, BR; Rock-Kress, D; Metcalf, JA; Davey, RT; Falloon, J; Kovacs, JA; Polis, RA; Walker, RE; Masur, H; Lane, HC
      Immunotherapy of HIV-infected patients with intermittent interleukin-2: Effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion

      CLINICAL IMMUNOLOGY
    57. Ellis, TM; Le, PT; DeVries, G; Stubbs, E; Fisher, M; Bhoopalam, N
      Alterations in CD30(+) T cells in monoclonal gammopathy of undetermined significance

      CLINICAL IMMUNOLOGY
    58. Newman, R; Hariharan, K; Reff, M; Anderson, DR; Braslawsky, G; Santoro, D; Hanna, N; Bugelski, PJ; Brigham-Burke, M; Crysler, C; Gagnon, RC; Dal Monte, P; Doyle, ML; Hensley, PC; Reddy, MP; Sweet, RW; Truneh, A
      Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees

      CLINICAL IMMUNOLOGY
    59. Gausling, R; Trollmo, C; Hafler, DA
      Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patients with relapsing-remitting multiple sclerosis

      CLINICAL IMMUNOLOGY
    60. Anderson, DE; Carlos, MP; Nguyen, L; Torres, JV
      Overcoming original (antigenic) sin

      CLINICAL IMMUNOLOGY
    61. Dyrhol-Riise, AM; Stent, G; Rosok, BI; Voltersvik, P; Olofsson, J; Asjo, B
      The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissueduring highly active antiretroviral therapy

      CLINICAL IMMUNOLOGY
    62. Dyrhol-Riise, AM; Ohlsson, M; Skarstein, K; Nygaard, SJT; Olofsson, J; Jonsson, R; Asjo, B
      T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: Impact of highly active antiretroviral therapy

      CLINICAL IMMUNOLOGY
    63. Lee, SY; Huang, CK; Zhang, TF; Schofield, BH; Burks, AW; Bannon, GA; Sampson, HA; Li, XM
      Oral administration of IL-12 suppresses anaphylactic reactions in a murinemodel of peanut hypersensitivity

      CLINICAL IMMUNOLOGY
    64. Sperling, AI
      ICOS costimulation: Is it the key to selective immunotherapy?

      CLINICAL IMMUNOLOGY
    65. Kalinkovich, A; Borkow, G; Weisman, Z; Tsimanis, A; Stein, M; Bentwich, Z
      Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: Environmental and constitutive factors

      CLINICAL IMMUNOLOGY
    66. Gomes, NA; DosReis, GA
      The dual role of CTLA-4 in Leishmania infection

      TRENDS IN PARASITOLOGY
    67. Hackstein, H; Morelli, AE; Thomson, AW
      Designer dendritic cells for tolerance induction: guided not misguided missiles

      TRENDS IN IMMUNOLOGY
    68. Goldman, M; Le Moine, A; Braun, M; Flamand, V; Abramowicz, D
      A role for eosinophils in transplant rejection

      TRENDS IN IMMUNOLOGY
    69. Mahlknecht, U; Herbein, G
      Macrophages and T-cell apoptosis in HIV infection: a leading role for accessory cells?

      TRENDS IN IMMUNOLOGY
    70. Appay, V; Rowland-Jones, SL
      RANTES: a versatile and controversial chemokine

      TRENDS IN IMMUNOLOGY
    71. Montaner, LJ
      Structured treatment interruptions to control HIV-1 and limit drug exposure

      TRENDS IN IMMUNOLOGY
    72. Wohlleben, G; Erb, KJ
      Atopic disorders: a vaccine around the corner?

      TRENDS IN IMMUNOLOGY
    73. Veazey, RS; Marx, PA; Lackner, AA
      The mucosal immune system: primary target for HIV infection and AIDS

      TRENDS IN IMMUNOLOGY
    74. Imami, N; Hardy, G; Gotch, F
      Development of immunotherapeutic strategies for HIV-1

      EXPERT OPINION ON BIOLOGICAL THERAPY
    75. Geyer, M; Fackler, OT; Peterlin, BM
      Structure-function relationships in HIV-1 Nef

      EMBO REPORTS
    76. Schluger, NW
      Recent advances in our understanding of human host responses to tuberculosis

      RESPIRATORY RESEARCH
    77. Davis, LS; Cush, JJ; Schulze-Koops, H; Lipsky, PE
      Rheumatoid synovial CD4(+) T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cells

      ARTHRITIS RESEARCH
    78. Isaacs, JD
      From bench to bedside: discovering rules for antibody design, and improving serotherapy with monoclonal antibodies

      RHEUMATOLOGY
    79. Kaufmann, J; Franke, S; Kientsch-Engel, R; Oelzner, P; Hein, G; Stein, G
      Correlation of circulating interleukin 16 with proinflammatory cytokines in patients with rheumatoid arthritis

      RHEUMATOLOGY
    80. Gratchev, A; Schledzewski, K; Guillot, P; Goerdt, S
      Alternatively activated antigen-presenting cells: Molecular repertoire, immune regulation, and healing

      SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY
    81. Narula, S; Cuss, F
      Interleukin-10

      NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    82. Li, C; Dowd, CS; Zhang, W; Chaiken, IM
      Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences

      JOURNAL OF PEPTIDE RESEARCH
    83. Dowd, CS; Zhang, WT; Li, CZ; Chaiken, IM
      From receptor recognition mechanisms to bioinspired mimetic antagonists inHIV-1/cell docking

      JOURNAL OF CHROMATOGRAPHY B
    84. Coadou, G; Evrard-Todeschi, N; Gharbi-Benarous, J; Benarous, R; Girault, JP
      Conformational analysis by NMR and molecular modelling of the 41-62 hydrophilic region of HIV-1 encoded virus protein U (Vpu). Effect of the phosphorylation on sites 52 and 56

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE II FASCICULE C-CHIMIE
    85. Turville, SG; Cameron, PU; Arthos, J; MacDonald, K; Clark, G; Hart, D; Cunningham, AL
      Bitter-sweet symphony: defining the role of dendritic cell gp120 receptorsin HIV infection

      JOURNAL OF CLINICAL VIROLOGY
    86. Mijch, AM; Hoy, J; Watson, K; Dunne, A; Crowe, S; Wesselingh, SL
      Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years?

      JOURNAL OF CLINICAL VIROLOGY
    87. Pett, SL; Emery, S
      Immunomodulators as adjunctive therapy for HIV-1 infection

      JOURNAL OF CLINICAL VIROLOGY
    88. Garcia-Lerma, JG; Heneine, W
      Resistance of human immunodeficiency virus type 1 to reverse transcriptaseand protease inhibitors: genotypic and phenotypic testing

      JOURNAL OF CLINICAL VIROLOGY
    89. Alfano, M; Poli, G
      Cytokine and chemokine based control of HIV infection and replication

      CURRENT PHARMACEUTICAL DESIGN
    90. Miller, MD; Hazuda, DJ
      New antiretroviral agents: looking beyond protease and reverse transcriptase

      CURRENT OPINION IN MICROBIOLOGY
    91. Ampel, NM; Kramer, LA; Kerekes, KM; Johnson, SM; Pappagianis, D
      Assessment of the human cellular immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood

      MEDICAL MYCOLOGY
    92. Bondeson, J; Maini, RN
      Tumour necrosis factor as a therapeutic target in rheumatoid arthritis andother chronic inflammatory diseases: The clinical experience with infliximab (Remicade (TM))

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    93. Lever, AML
      Gene therapy for HIV

      SEXUALLY TRANSMITTED INFECTIONS
    94. Roshal, M; Zhu, Y; Planelles, V
      Apoptosis in AIDS

      APOPTOSIS
    95. Yang, Y; Ashwell, JD
      Exploiting the apoptotic process for management of HIV: Are we there yet ?

      APOPTOSIS
    96. Lange, J
      A rational approach to the selection and sequencing of nucleoside/nucleotide analogues: a new paradigm

      ANTIVIRAL THERAPY
    97. House, SD; Guidon, PT; Perdrizet, GA; Rewinski, M; Kyriakos, R; Bockman, RS; Mistry, T; Gallagher, PA; Hightower, LE
      Effects of heat shock, stannous chloride, and gallium nitrate on the vat inflammatory response

      CELL STRESS & CHAPERONES
    98. Rausch, DM; Davis, MR
      HIV in the CNS: Pathogenic relationships to systemic HIV disease and otherCNS diseases

      JOURNAL OF NEUROVIROLOGY
    99. Stins, MF; Shen, Y; Huang, SH; Gilles, F; Kalra, VK; Kim, KS
      Gp120 activates children's brain endothelial cells via CD4

      JOURNAL OF NEUROVIROLOGY
    100. Shieh, TM; Carter, DL; Blosser, RL; Mankowski, JL; Zink, MC; Clements, JE
      Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus

      JOURNAL OF NEUROVIROLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 18:39:41